Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study

RATIONALE AND OBJECTIVE: Chronic kidney disease is a risk enhancing factor for cardiovascular disease (CVD) and mortality, and the role of aspirin use is unclear in this population. We investigated the risk and benefits of aspirin use in primary and secondary prevention of CVD in the Chronic Renal I...

Descripción completa

Detalles Bibliográficos
Autores principales: Taliercio, Jonathan J., Nakhoul, Georges, Mehdi, Ali, Yang, Wei, Sha, Daohang, Schold, Jesse D., Kasner, Scott, Weir, Matthew, Hassanein, Mohamed, Navaneethan, Sankar D., Krishnan, Geetha, Kanthety, Radhika, Go, Alan S., Deo, Rajat, Lora, Claudia M., Jaar, Bernard G., Chen, Teresa K., Chen, Jing, He, Jiang, Rahman, Mahboob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630782/
https://www.ncbi.nlm.nih.gov/pubmed/36339663
http://dx.doi.org/10.1016/j.xkme.2022.100547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630782/
https://www.ncbi.nlm.nih.gov/pubmed/36339663
http://dx.doi.org/10.1016/j.xkme.2022.100547

Ejemplares similares